This content is machine translated Efficacy Check Multiple levels of effectiveness The two completed phase III studies SUNBEAM [1] and RADIANCE [2] were able to demonstrate the efficacy of the new active substance in the area of other – radiological and…
View Post 5 min This content is machine translated Ozanimod A new player in MS therapy With the recently approved ozanimod, another potent compound for the treatment of adults with relapsing-remitting multiple sclerosis (RRMS) is entering the Swiss market. The oral sphingosine-1-phosphate (S1P) receptor modulator demonstrated…
View Post 6 min This content is machine translated Diabetic polyneuropathy Measure nerve conduction velocity for diagnosis Diabetic polyneuropathy (dPNP) is the most common neuropathy in Western countries. But who gets them and how do you recognize them? This question is particularly important because 40% of those…
View Post 2 min This content is machine translated MS experts of the future New Master’s Program “Multiple Sclerosis Management” launched Medicine and its training are constantly evolving and adapting to new realities. Because multiple sclerosis is a disease with a thousand faces, there is a high demand for specialized professionals.…
View Post 12 min This content is machine translated Venous thromboembolism Risks associated with hormone therapy Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism… CME-Test
View Post 2 min This content is machine translated Essential tremor With surface electrostimulation against tremor A recent study from London/UK shows that non-invasive stimulation with surface electrodes can reduce the intensity of hand tremor in patients with essential tremor. Dr. Dr. Sebastian Schreglmann and Dr.…
View Post 3 min This content is machine translated Multiple sclerosis First animal data on mRNA vaccination against multiple sclerosis A recent study [1] is attracting a lot of attention, especially in expert circles, because a few weeks after the introduction of the first mRNA-based Corona vaccines, an mRNA vaccination…
View Post 4 min This content is machine translated Tau antibodies against neurodegenerative diseases New findings from global PSP clinical trial Progressive Supranuclear Gaze Palsy (PSP) is a chronic progressive neurodegene-rative disease which, like Alzheimer’s disease, is one of the so-called tauopathies. To date, there is no causal treatment for these…
View Post 3 min This content is machine translated Spinal muscular atrophy Therapy goals in adult SMA patients firmly in view Spinal muscular atrophy, although a rare condition, is among the most common genetic causes of death in infants and young children. However, adolescents and adults can also be affected by…
View Post 2 min This content is machine translated Migraine Prophylaxis or acute therapy: focus on severe migraine Migraine, along with tension headache, is one of the most common of the more than 240 types of headache and significantly limits the quality of life and daily routine of…
View Post 1 min This content is machine translated Multiple sclerosis Cladribine tablets show rapid onset of action Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is the most common non-traumatic neurological disease leading to severe impairment in young adults.